Literature DB >> 15247175

Altered visceral perceptual and neuroendocrine response in patients with irritable bowel syndrome during mental stress.

I Posserud1, P Agerforz, R Ekman, E S Björnsson, H Abrahamsson, M Simrén.   

Abstract

BACKGROUND AND AIMS: Stress often worsens the symptoms of irritable bowel syndrome (IBS). We hypothesised that this might be explained by altered neuroendocrine and visceral sensory responses to stress in IBS patients. SUBJECTS AND METHODS: Eighteen IBS patients and 22 control subjects were assessed using rectal balloon distensions before, during, and after mental stress. Ten controls and nine patients were studied in supplementary sessions. Rectal sensitivity (thresholds and intensity-visual analogue scale (VAS)) and perceived stress and arousal (VAS) were determined. Plasma levels of corticotropin releasing factor (CRF), adrenocorticotropic hormone (ACTH), cortisol, noradrenaline, and adrenaline were analysed at baseline, immediately after stress, and after the last distension. Heart rate was recorded continuously.
RESULTS: Thresholds were increased during stress in control subjects (p<0.01) but not in IBS patients. Both groups showed lower thresholds after stress (p<0.05). Repeated distensions without stress did not affect thresholds. Both groups showed increased heart rate (p<0.001) and VAS ratings for stress and arousal (p<0.05) during stress. Patients demonstrated higher ratings for stress but lower for arousal than controls. Basal CRF levels were lower in patients (p<0.05) and increased significantly during stress in patients (p<0.01) but not in controls. Patients also responded with higher levels of ACTH during stress (p<0.05) and had higher basal levels of noradrenaline than controls (p<0.01). Controls, but not patients, showed increased levels of adrenaline and noradrenaline in response to stress (p<0.05).
CONCLUSIONS: Stress induced exaggeration of the neuroendocrine response and visceral perceptual alterations during and after stress may explain some of the stress related gastrointestinal symptoms in IBS.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15247175      PMCID: PMC1774150          DOI: 10.1136/gut.2003.017962

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


  41 in total

Review 1.  The neurobiology of stress and gastrointestinal disease.

Authors:  E A Mayer
Journal:  Gut       Date:  2000-12       Impact factor: 23.059

Review 2.  Functional bowel disorders and functional abdominal pain.

Authors:  W G Thompson; G F Longstreth; D A Drossman; K W Heaton; E J Irvine; S A Müller-Lissner
Journal:  Gut       Date:  1999-09       Impact factor: 23.059

Review 3.  The Stroop color-word test: a review.

Authors:  A R Jensen; W D Rohwer
Journal:  Acta Psychol (Amst)       Date:  1966

Review 4.  V. Stress and irritable bowel syndrome.

Authors:  E A Mayer; B D Naliboff; L Chang; S V Coutinho
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2001-04       Impact factor: 4.052

5.  Irritable bowel syndrome patients show altered sensitivity to exogenous opioids.

Authors:  Tony Lembo; Bruce D Naliboff; Kamran Matin; Julie Munakata; Robert A Parker; Richard H Gracely; Emeran A Mayer
Journal:  Pain       Date:  2000-08       Impact factor: 6.961

6.  Pituitary-adrenal and autonomic responses to stress in women after sexual and physical abuse in childhood.

Authors:  C Heim; D J Newport; S Heit; Y P Graham; M Wilcox; R Bonsall; A H Miller; C B Nemeroff
Journal:  JAMA       Date:  2000-08-02       Impact factor: 56.272

7.  Evidence for two distinct perceptual alterations in irritable bowel syndrome.

Authors:  B D Naliboff; J Munakata; S Fullerton; R H Gracely; A Kodner; F Harraf; E A Mayer
Journal:  Gut       Date:  1997-10       Impact factor: 23.059

8.  Acute and chronic stress differently affect visceral sensitivity to rectal distension in female rats.

Authors:  S Bradesi; H Eutamene; R Garcia-Villar; J Fioramonti; L Buéno
Journal:  Neurogastroenterol Motil       Date:  2002-02       Impact factor: 3.598

9.  Abnormal levels of neuropeptide Y and peptide YY in the colon in irritable bowel syndrome.

Authors:  Magnus Simrén; Per-Ove Stotzer; Henrik Sjövall; Hasse Abrahamsson; Einar S Björnsson
Journal:  Eur J Gastroenterol Hepatol       Date:  2003-01       Impact factor: 2.566

10.  Irritable bowel syndrome patients show enhanced modulation of visceral perception by auditory stress.

Authors:  Britta Dickhaus; Emeran A Mayer; Nazanin Firooz; Jean Stains; Francisco Conde; Teresa I Olivas; Ronnie Fass; Lin Chang; Minou Mayer; Bruce D Naliboff
Journal:  Am J Gastroenterol       Date:  2003-01       Impact factor: 10.864

View more
  83 in total

Review 1.  Meditation over medication for irritable bowel syndrome? On exercise and alternative treatments for irritable bowel syndrome.

Authors:  Fredrick Asare; Stine Störsrud; Magnus Simrén
Journal:  Curr Gastroenterol Rep       Date:  2012-08

2.  Visceral analgesia induced by acute and repeated water avoidance stress in rats: sex difference in opioid involvement.

Authors:  M Larauche; A Mulak; Y S Kim; J Labus; M Million; Y Taché
Journal:  Neurogastroenterol Motil       Date:  2012-07-09       Impact factor: 3.598

3.  Acupuncture treatment in irritable bowel syndrome.

Authors:  A Schneider; P Enck; K Streitberger; C Weiland; S Bagheri; S Witte; H-C Friederich; W Herzog; S Zipfel
Journal:  Gut       Date:  2005-09-08       Impact factor: 23.059

Review 4.  Challenges to the therapeutic pipeline for irritable bowel syndrome: end points and regulatory hurdles.

Authors:  Michael Camilleri; Lin Chang
Journal:  Gastroenterology       Date:  2008-10-09       Impact factor: 22.682

Review 5.  New insights into visceral hypersensitivity--clinical implications in IBS.

Authors:  QiQi Zhou; G Nicholas Verne
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2011-06       Impact factor: 46.802

6.  Treatment of Functional GI Disorders With Psychotropic Medicines: A Review of Evidence With a Practical Approach.

Authors:  Syed I M Thiwan; Douglas A Drossman
Journal:  Gastroenterol Hepatol (N Y)       Date:  2006-09

7.  Effects of fluoxetine on mast cell morphology and protease-1 expression in gastric antrum in a rat model of depression.

Authors:  Zhen-Hua Chen; Ling Xiao; Ji-Hong Chen; He-Shen Luo; Gao-Hua Wang; Yong-Lan Huang; Xiao-Ping Wang
Journal:  World J Gastroenterol       Date:  2008-12-07       Impact factor: 5.742

8.  Frequency of small intestinal bacterial overgrowth in patients with irritable bowel syndrome and chronic non-specific diarrhea.

Authors:  Uday C Ghoshal; Sunil Kumar; Mansi Mehrotra; Cp Lakshmi; Asha Misra
Journal:  J Neurogastroenterol Motil       Date:  2010-01-31       Impact factor: 4.924

9.  Asian motility studies in irritable bowel syndrome.

Authors:  Oh Young Lee
Journal:  J Neurogastroenterol Motil       Date:  2010-04-27       Impact factor: 4.924

10.  Central and peripheral hypersensitivity in the irritable bowel syndrome.

Authors:  QiQi Zhou; Roger B Fillingim; Joseph L Riley; William B Malarkey; G Nicholas Verne
Journal:  Pain       Date:  2010-01-13       Impact factor: 6.961

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.